Funding Opportunities

 This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.

Standard submission dates apply for all listings, unless otherwise noted.

Guidance For Investigators Planning to Submit a Program Project Grant (P01)

Notice: Internet links not permitted in NIH Grant Applications

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Title Announcement # Expiration Date Research Focus
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems PAR-20-155 (R01 Clinical Trial Optional) 09/08/2022
    • Cancer Biomarkers
Administrative Supplement for Research on Dietary Supplements PA-20-227 (Admin Supp-Clinical Trial Not Allowed) 04/16/2023
    • Nutritional Science
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PAR-22-114 01/24/2025
    • US-Latin American-Caribbean U54
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-314 (UH3 Clinical Trials Not Allowed) 10/11/2023
    • Cancer Biomarkers
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) 10/11/2023
    • Cancer Biomarkers
Basic Research in Cancer Health Disparities PAR-21-324 (R03 Clinical Trial Not Allowed) 09/08/2024
    • Gastrointestinal and Other Cancers
Basic Research in Cancer Health Disparities PAR-21-322 (R01 Clinical Trial Not Allowed) 09/08/2024
    • Gastrointestinal and Other Cancers
Basic Research in Cancer Health Disparities PAR-21-323 (R21 Clinical Trial Not Allowed) 09/08/2024
    • Gastrointestinal and Other Cancers
Cancer Prevention and Control Clinical Trials Grant Program PAR-21-035 (R01 Clinical Trial Required) 01/08/2024
    • Breast and Gynecologic Cancer
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health RFA-CA-22-020 (U01 Clinical Trial Optional) 06/18/2022
    • US-Latin American-Caribbean U54
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-22-099 (R01 Clinical Trial Optional) 05/08/2025
    • Cancer Biomarkers
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-21-329 (R01 Clinical Trial Optional) 11/06/2024
    • Community Oncology and Prevention Trials
Co-infection and Cancer PAR-20-062 (R01 Clinical Trial Not Allowed) 01/08/2023
    • Cancer Biomarkers
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome RFA-TR-22-011 (R21 Clinical Trial Not Allowed) 05/23/2023
    • Supportive Care and Symptom Management
Emergency Awards: HEAL Initiative- New Innovator Award RFA-TR-22-013 (DP2 Clinical Trial Not Allowed) 05/23/2023
    • Supportive Care and Symptom Management
HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells RFA-NS-22-018 (U19 Clinical Trial Not Allowed) 03/10/2023
    • Supportive Care and Symptom Management
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment RFA-NS-22-034 (R01 Clinical Trial Not Allowed) 12/07/2024
    • Supportive Care and Symptom Management
HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) RFA-NS-22-050 02/24/2023
    • Supportive Care and Symptom Management
HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center RFA-NS-22-021 (U24 Clinical Trial Not Allowed) 10/12/2022
    • Supportive Care and Symptom Management
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity PAR-22-092 (R01 - Clinical Trials Optional) 09/08/2024
    • Supportive Care and Symptom Management
    • Community Oncology and Prevention Trials
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-331 (R01 Clinical Trial Optional) 09/08/2024
    • Breast and Gynecologic Cancer
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-332 (R21 Clinical Trial Not Allowed) 09/08/2024
    • Breast and Gynecologic Cancer
Music and Health: Understanding And Developing Music Medicine PAR-21-100 (R01 Clinical Trial Optional) 02/06/2023
    • Supportive Care and Symptom Management
Music and Health: Understanding And Developing Music Medicine PAR-21-099 (R21 Clinical Trial Optional) 02/17/2023
    • Supportive Care and Symptom Management
NCI Clinical and Translational Exploratory/Developmental Studies PAR-20-292 (R21 Clinical Trial Optional) 07/21/2022
    • Breast and Gynecologic Cancer
NIH Research Project Grant PA-20-185 (Parent R01 Clinical Trial Not Allowed) 05/08/2023
    • Nutritional Science
Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection NOT-CA-20-067 (R01 Clinical Trial Not Allowed) 01/08/2023
    • Cancer Biomarkers
Notice of Correction to PAR-21-035, Cancer Prevention and Control Clinical Trials Grant Program NOT-CA-22-012 (R01 Clinical Trials Required) 01/08/2024
    • All DCP Research Groups
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention and Control Clinical Trials Planning Grant NOT-CA-22-062 (U34 Clinical Trials Optional) 07/15/2022
    • Breast and Gynecologic Cancer
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention and Control Clinical Trials Planning Grant Program NOT-CA-22-061 (R34 Clinical Trials Optional) 07/15/2022
    • Breast and Gynecologic Cancer
Notice of NCI Participation in PAR-22-064, Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities NOT-CA-22-048 (R01 Clinical Trial Optional) 01/08/2025
    • Supportive Care and Symptom Management
    • Community Oncology and Prevention Trials
Notice of Special Interest: Advancing the Science of Geriatric Palliative Care NOT-AG-20-041 09/08/2023
    • Supportive Care and Symptom Management
    • Community Oncology and Prevention Trials
Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications NOT-DK-20-001 01/08/2023
    • Nutritional Science
Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants NOT-CA-21-070 05/16/2023
    • Gastrointestinal and Other Cancers
Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia NOT-CA-21-057 05/08/2023
    • Lung and Upper Aerodigestive Cancer
Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults NOT-CA-21-108 05/08/2023
    • Nutritional Science
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 11/06/2024
    • Supportive Care and Symptom Management
Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers NOT-CA-21-028 01/08/2024
    • Cancer Biomarkers
    • Gastrointestinal and Other Cancers
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 05/08/2023
    • Cancer Biomarkers
Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones NOT-DK-20-002 01/08/2023
    • Nutritional Science
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) NOT-NS-20-107 05/16/2024
    • Supportive Care and Symptom Management
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit PAR-21-335 (U24 Clinical Trial Not Allowed) 06/12/2024
    • Pancreatic Cancer Detection Consortium
    • Cancer Biomarkers
Pancreatic Cancer Detection Consortium: Research Units PAR-21-334 (U01 Clinical Trial Optional) 06/12/2024
    • Pancreatic Cancer Detection Consortium
    • Cancer Biomarkers
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities PAR-22-064 (R01 Clinical Trial Optional) 01/08/2025
    • Supportive Care and Symptom Management
    • Community Oncology and Prevention Trials
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection PAR-20-053 (R01 Clinical Trial Not Allowed) 01/08/2023
    • Cancer Biomarkers
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions PAR-20-266 (R61/R33 Clinical Trial Optional) 06/20/2023
    • Supportive Care and Symptom Management
Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Advancing Research in Immuno-oncology, Immunoprevention, and/or Immunotherapy. NOT-CA-22-072 07/01/2022
    • Chemopreventive Agent Development
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants PAR-20-074 (R01 Clinical Trial Not Allowed) 10/29/2022
    • Gastrointestinal and Other Cancers
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-276 (R01 Clinical Trial Not Allowed) 09/08/2022
    • Cancer Biomarkers
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-277 (R21 Clinical Trials Not Allowed) 09/08/2022
    • Cancer Biomarkers
Stephen I. Katz Early Stage Investigator Research Project Grant PAR-21-038 (R01 Clinical Trial Not Allowed) 12/29/2023
    • All DCP Research Groups
Stephen I. Katz Early Stage Investigator Research Project Grant PAR-21-039 (R01 Basic Experimental Studies with Humans Required) 12/29/2023
    • All DCP Research Groups
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-21-330 (U01 Clinical Trial Not Allowed) 10/12/2024
    • Early Detection